NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
13 trialsNCT06062745 2025-11-05
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Brigham and Women's Hospital
Phase 1 Recruiting
NCT06479187 2025-11-05
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
Brigham and Women's Hospital
Phase 4 Active not recruiting
NCT06914427 2025-04-06
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
Xijing Hospital
Phase NA Not yet recruiting
NCT03803475 2021-08-24
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
University of California, San Francisco
Phase 3 Completed
NCT02559115 2021-05-18
68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02611882 2020-12-22
PSMA PET
University of California, San Francisco
Phase 2 Completed
NCT01479348 2020-06-02
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT02964988 2019-10-15
uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Rigshospitalet, Denmark
Phase 2 Terminated
NCT02042053 2017-07-18
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
NYU Langone Health
Phase NA Terminated
NCT03094897 2017-04-13
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics
Wuxi No. 4 People's Hospital
Phase EARLY_PHASE1 Unknown
NCT02002455 2016-10-21
Flucipro
Turku University Hospital
Phase 2 Completed
NCT02181192 2016-08-01
PROST-I
University of Erlangen-Nürnberg Medical School
Phase NA Unknown